Designer drug (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Designer drug" in English language version.

refsWebsite

Global rank English rank

20doi.org

2^nd place

18nih.gov

4^th place

6semanticscholar.org

11^th place

8^th place

4europa.eu

68^th place

117^th place

3web.archive.org

1^st place

3bbc.co.uk

8^th place

10^th place

2harvard.edu

18^th place

17^th place

1drugwarfacts.org

low place

1researchgate.net

120^th place

125^th place

1unodc.org

2,494^th place

2,269^th place

1erowid.org

3,887^th place

3,197^th place

1thedea.org

low place

1zenodo.org

621^st place

380^th place

1badische-zeitung.de

2,399^th place

low place

1salford.ac.uk

low place

9,316^th place

1theguardian.com

12^th place

11^th place

1themarkup.org

low place

1worldcat.org

5^th place

19news.com.au

4,754^th place

2,875^th place

1nationalarchives.gov.uk

744^th place

547^th place

1drugs.homeoffice.gov.uk

low place

1al.com

963^rd place

540^th place

1cnn.com

28^th place

26^th place

1nytimes.com

7^th place

1webmd.com

1,169^th place

1,075^th place

1sverigesradio.se

1,180^th place

2,079^th place

1austlii.edu.au

1,812^th place

995^th place

1anvisa.gov.br

low place

9news.com.au

"Uncovering the peptide 'grey market' sweeping Australia". www.9news.com.au. 2017-06-29. Retrieved 2023-10-24.

al.com

blog.al.com

Cumbow V (2011-02-06). "Synthetic form of cocaine and methamphetamine being packaged as bath salts". The Huntsville Times. Retrieved 2011-02-10.

anvisa.gov.br

antigo.anvisa.gov.br

"Combate a drogas ilícitas sintéticas fica mais fácil" [Combating synthetic illicit drugs just got easier]. Agência Nacional de Vigilância Sanitária (ANVISA) (in Portuguese). Brazilian Government.

austlii.edu.au

"Drug Misuse and Trafficking Act 1985 - Schedule 1".

badische-zeitung.de

"Spice enthält chemischen Wirkstoff" [Spice contains chemical agent]. Badishce Zietung (in German). December 2008.

bbc.co.uk

news.bbc.co.uk

"EU struggles to curb hard drugs". BBC News. 5 November 2009.
"Police warning over 'bubble' drug". BBC News. 20 November 2009. Retrieved 2009-11-27.
Reed J (13 January 2010). "Clubbers are 'turning to new legal high mephedrone'". BBC News. Retrieved 2010-07-04.

cnn.com

news.blogs.cnn.com

"Reports: Miami 'zombie' attacker may have been using 'bath salts'". CNN. May 29, 2012. Archived from the original on March 25, 2021. Retrieved May 29, 2012.

doi.org

Wohlfarth A, Weinmann W (May 2010). "Bioanalysis of new designer drugs". Bioanalysis. 2 (5): 965–979. doi:10.4155/bio.10.32. PMID 21083227.
Teale P, Scarth J, Hudson S (January 2012). "Impact of the emergence of designer drugs upon sports doping testing". Bioanalysis. 4 (1): 71–88. doi:10.4155/bio.11.291. PMID 22191595.
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (February 2012). "Designer drugs: a medicinal chemistry perspective". Annals of the New York Academy of Sciences. 1248 (1): 18–38. Bibcode:2012NYASA1248...18C. doi:10.1111/j.1749-6632.2011.06199.x. PMID 22092008. S2CID 5108266.
Reneman L (2003). "Designer drugs: How dangerous are they?". Addiction Mechanisms, Phenomenology and Treatment. pp. 61–83. doi:10.1007/978-3-7091-0541-2_4. ISBN 978-3-211-01316-8. PMID 14582803. {{cite book}}: |journal= ignored (help)
Buchanan JF, Brown CR (1988). "'Designer drugs'. A problem in clinical toxicology". Med Toxicol Adverse Drug Exp. 3 (1): 1–17. doi:10.1007/bf03259928. PMID 3285124. S2CID 28335757.
Snyder SH, Faillace L, Hollister L (1967). "2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug". Science. 158 (3801): 669–70. Bibcode:1967Sci...158..669S. doi:10.1126/science.158.3801.669. PMID 4860952. S2CID 24065654.
Fahn S (1996). "The Case of the Frozen Addicts: How the Solution of an Extraordinary Medical Mystery Spawned a Revolution in the Understanding and Treatment of Parkinson's Disease". The New England Journal of Medicine. 335 (26): 2002–2003. doi:10.1056/NEJM199612263352618.
Henderson GL (1988). "Designer drugs: past history and future prospects". J. Forensic Sci. 33 (2): 569–75. doi:10.1520/JFS11976J. PMID 3286815.
Cole MD, Lea C, Oxley N (2002). "4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature". Sci. Justice. 42 (4): 223–4. doi:10.1016/S1355-0306(02)71832-7. PMID 12632938.
de Boer D, Bosman I (2004). "A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs". Pharm World Sci. 26 (2): 110–3. doi:10.1023/b:phar.0000018600.03664.36. PMID 15085947. S2CID 35546712.
Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2008). "[Analysis of designer drugs detected in the products purchased in fiscal year 2006]". Yakugaku Zasshi. 128 (10): 1499–505. doi:10.1248/yakushi.128.1499. PMID 18827471.
Malvey TC, Armsey TD (2005). "Tetrahydrogestrinone: the discovery of a designer steroid". Curr Sports Med Rep. 4 (4): 227–30. doi:10.1097/01.csmr.0000306213.87433.11. PMID 16004834. S2CID 220574624.
Reepmeyer JC, Woodruff JT, d'Avignon DA (2007). "Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement". J Pharm Biomed Anal. 43 (5): 1615–21. doi:10.1016/j.jpba.2006.11.037. PMID 17207601.
Venhuis BJ, Blok-Tip L, de Kaste D (2008). "Designer drugs in herbal aphrodisiacs". Forensic Sci. Int. 177 (2–3): e25-7. doi:10.1016/j.forsciint.2007.11.007. PMID 18178354.
Evans-Brown M, Dawson RT, Chandler M, McVeigh J (2009). "Use of melanotan I and II in the general population". BMJ. 338: b566. doi:10.1136/bmj.b566. PMID 19224885. S2CID 43121906.
Measham F, Moore K, Newcombe R, Smith Z (12 March 2010). "Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition". Drugs and Alcohol Today. 10 (1): 14–21. doi:10.5042/daat.2010.0123.(subscription required)
Turnock, Luke; Gibbs, Nick (2023-06-01). "Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK". Performance Enhancement & Health. 11 (2): 100251. doi:10.1016/j.peh.2023.100251. ISSN 2211-2669.
Fattore L, Fratta W (2011-09-21). "Beyond THC: The New Generation of Cannabinoid Designer Drugs". Frontiers in Behavioral Neuroscience. 5: 60. doi:10.3389/fnbeh.2011.00060. PMC 3187647. PMID 22007163.
Andreasen MF, Telving R, Birkler RI, Schumacher B, Johannsen M (2009). "A fatal poisoning involving Bromo-Dragonfly". Forensic Sci. Int. 183 (1–3): 91–6. doi:10.1016/j.forsciint.2008.11.001. PMID 19091499.
Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009). "Spice: a never ending story?". Forensic Sci. Int. 191 (1–3): 58–63. doi:10.1016/j.forsciint.2009.06.008. PMID 19589652.

drugs.homeoffice.gov.uk

"Consideration of the cathinones" (PDF). Advisory Council on the Misuse of Drugs. 31 March 2010. p. 25. Archived from the original (PDF) on 2 April 2010. Retrieved 1 April 2010.

drugwarfacts.org

"New Psychoactive Substances (NPS)". Drug War Facts. Common Sense for Drug Policy. 8 July 2021. The term 'new psychoactive substances' had been legally defined by the European Union as a new narcotic or psychotropic drug, in pure form or in a preparation, that is not scheduled under the Single Convention on Narcotic Drugs of 1961 or the Convention on Psychotropic Substances of 1971, but which may pose a public health threat comparable to that posed by substances listed in those conventions (Council of the European Union decision 2005/387/JHA).

erowid.org

Cooper DA (March 1988). Future Synthetic Drugs of Abuse. Proceedings of the international symposium on the forensic aspects of controlled substances. McLean, Virginia: Drug Enforcement Administration. p. 79.

europa.eu

emcdda.europa.eu

"2009 Annual report: the state of the drugs problem in Europe" (PDF). Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Archived from the original (PDF) on 2009-11-16. Retrieved 2009-11-05.
"EMCDDA–Europol 2013 Annual Report on the information exchange, risk assessment and control of new psychoactive substances (implementation of Council Decision 2005/387/JHA)". EMCDDA. July 2014. Retrieved 8 August 2014.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2021). "Synthetic cannabinoids in Europe – a review" (PDF). Luxembourg: Publications Office of the European Union.
"Ireland passes new law to control 'head shops' and 'legal highs'". European Monitoring Centre for Drugs and Drug Addiction.

harvard.edu

ui.adsabs.harvard.edu

Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (February 2012). "Designer drugs: a medicinal chemistry perspective". Annals of the New York Academy of Sciences. 1248 (1): 18–38. Bibcode:2012NYASA1248...18C. doi:10.1111/j.1749-6632.2011.06199.x. PMID 22092008. S2CID 5108266.
Snyder SH, Faillace L, Hollister L (1967). "2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug". Science. 158 (3801): 669–70. Bibcode:1967Sci...158..669S. doi:10.1126/science.158.3801.669. PMID 4860952. S2CID 24065654.

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

"Consideration of the cathinones" (PDF). Advisory Council on the Misuse of Drugs. 31 March 2010. p. 25. Archived from the original (PDF) on 2 April 2010. Retrieved 1 April 2010.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wohlfarth A, Weinmann W (May 2010). "Bioanalysis of new designer drugs". Bioanalysis. 2 (5): 965–979. doi:10.4155/bio.10.32. PMID 21083227.
Teale P, Scarth J, Hudson S (January 2012). "Impact of the emergence of designer drugs upon sports doping testing". Bioanalysis. 4 (1): 71–88. doi:10.4155/bio.11.291. PMID 22191595.
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (February 2012). "Designer drugs: a medicinal chemistry perspective". Annals of the New York Academy of Sciences. 1248 (1): 18–38. Bibcode:2012NYASA1248...18C. doi:10.1111/j.1749-6632.2011.06199.x. PMID 22092008. S2CID 5108266.
Reneman L (2003). "Designer drugs: How dangerous are they?". Addiction Mechanisms, Phenomenology and Treatment. pp. 61–83. doi:10.1007/978-3-7091-0541-2_4. ISBN 978-3-211-01316-8. PMID 14582803. {{cite book}}: |journal= ignored (help)
Buchanan JF, Brown CR (1988). "'Designer drugs'. A problem in clinical toxicology". Med Toxicol Adverse Drug Exp. 3 (1): 1–17. doi:10.1007/bf03259928. PMID 3285124. S2CID 28335757.
Snyder SH, Faillace L, Hollister L (1967). "2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug". Science. 158 (3801): 669–70. Bibcode:1967Sci...158..669S. doi:10.1126/science.158.3801.669. PMID 4860952. S2CID 24065654.
Henderson GL (1988). "Designer drugs: past history and future prospects". J. Forensic Sci. 33 (2): 569–75. doi:10.1520/JFS11976J. PMID 3286815.
Cole MD, Lea C, Oxley N (2002). "4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature". Sci. Justice. 42 (4): 223–4. doi:10.1016/S1355-0306(02)71832-7. PMID 12632938.
de Boer D, Bosman I (2004). "A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs". Pharm World Sci. 26 (2): 110–3. doi:10.1023/b:phar.0000018600.03664.36. PMID 15085947. S2CID 35546712.
Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2008). "[Analysis of designer drugs detected in the products purchased in fiscal year 2006]". Yakugaku Zasshi. 128 (10): 1499–505. doi:10.1248/yakushi.128.1499. PMID 18827471.
Malvey TC, Armsey TD (2005). "Tetrahydrogestrinone: the discovery of a designer steroid". Curr Sports Med Rep. 4 (4): 227–30. doi:10.1097/01.csmr.0000306213.87433.11. PMID 16004834. S2CID 220574624.
Reepmeyer JC, Woodruff JT, d'Avignon DA (2007). "Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement". J Pharm Biomed Anal. 43 (5): 1615–21. doi:10.1016/j.jpba.2006.11.037. PMID 17207601.
Venhuis BJ, Blok-Tip L, de Kaste D (2008). "Designer drugs in herbal aphrodisiacs". Forensic Sci. Int. 177 (2–3): e25-7. doi:10.1016/j.forsciint.2007.11.007. PMID 18178354.
Evans-Brown M, Dawson RT, Chandler M, McVeigh J (2009). "Use of melanotan I and II in the general population". BMJ. 338: b566. doi:10.1136/bmj.b566. PMID 19224885. S2CID 43121906.
Fattore L, Fratta W (2011-09-21). "Beyond THC: The New Generation of Cannabinoid Designer Drugs". Frontiers in Behavioral Neuroscience. 5: 60. doi:10.3389/fnbeh.2011.00060. PMC 3187647. PMID 22007163.
Andreasen MF, Telving R, Birkler RI, Schumacher B, Johannsen M (2009). "A fatal poisoning involving Bromo-Dragonfly". Forensic Sci. Int. 183 (1–3): 91–6. doi:10.1016/j.forsciint.2008.11.001. PMID 19091499.
Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009). "Spice: a never ending story?". Forensic Sci. Int. 191 (1–3): 58–63. doi:10.1016/j.forsciint.2009.06.008. PMID 19589652.

ncbi.nlm.nih.gov

Fattore L, Fratta W (2011-09-21). "Beyond THC: The New Generation of Cannabinoid Designer Drugs". Frontiers in Behavioral Neuroscience. 5: 60. doi:10.3389/fnbeh.2011.00060. PMC 3187647. PMID 22007163.

nytimes.com

Goodnough A, Zezima K (2011-07-16). "An Alarming New Stimulant, Legal in Many States". New York Times. Retrieved 2012-01-15.

researchgate.net

Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (February 2012). "Designer drugs: a medicinal chemistry perspective". Annals of the New York Academy of Sciences. 1248 (1): 18–38. Bibcode:2012NYASA1248...18C. doi:10.1111/j.1749-6632.2011.06199.x. PMID 22092008. S2CID 5108266.

salford.ac.uk

usir.salford.ac.uk

Measham F, Moore K, Newcombe R, Smith Z (12 March 2010). "Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition". Drugs and Alcohol Today. 10 (1): 14–21. doi:10.5042/daat.2010.0123.(subscription required)

semanticscholar.org

api.semanticscholar.org

Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (February 2012). "Designer drugs: a medicinal chemistry perspective". Annals of the New York Academy of Sciences. 1248 (1): 18–38. Bibcode:2012NYASA1248...18C. doi:10.1111/j.1749-6632.2011.06199.x. PMID 22092008. S2CID 5108266.
Buchanan JF, Brown CR (1988). "'Designer drugs'. A problem in clinical toxicology". Med Toxicol Adverse Drug Exp. 3 (1): 1–17. doi:10.1007/bf03259928. PMID 3285124. S2CID 28335757.
Snyder SH, Faillace L, Hollister L (1967). "2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug". Science. 158 (3801): 669–70. Bibcode:1967Sci...158..669S. doi:10.1126/science.158.3801.669. PMID 4860952. S2CID 24065654.
de Boer D, Bosman I (2004). "A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs". Pharm World Sci. 26 (2): 110–3. doi:10.1023/b:phar.0000018600.03664.36. PMID 15085947. S2CID 35546712.
Malvey TC, Armsey TD (2005). "Tetrahydrogestrinone: the discovery of a designer steroid". Curr Sports Med Rep. 4 (4): 227–30. doi:10.1097/01.csmr.0000306213.87433.11. PMID 16004834. S2CID 220574624.
Evans-Brown M, Dawson RT, Chandler M, McVeigh J (2009). "Use of melanotan I and II in the general population". BMJ. 338: b566. doi:10.1136/bmj.b566. PMID 19224885. S2CID 43121906.

sverigesradio.se

Nu beslagtar svenska tullen lagliga droger, Sveriges Radio, 23 April 2011

thedea.org

"TheDEA.org: The History of MDMA". Archived from the original on 2016-07-14. Retrieved 2008-03-27.

theguardian.com

Power M (2014-10-31). "Drugs unlimited: how I created my very own legal high". The Guardian. Retrieved 7 August 2014.

themarkup.org

Gilbertson, Annie; Keegan, Jon (2020-09-17). "Labeled "Research" Chemicals, Doping Drugs Sold Openly on Amazon.com – The Markup". themarkup.org. Retrieved 2023-10-24.

unodc.org

"Esters of Morphine". UNODC Bulletin on Narcotics (2): 36–38. 1953.

web.archive.org

"TheDEA.org: The History of MDMA". Archived from the original on 2016-07-14. Retrieved 2008-03-27.
"2009 Annual report: the state of the drugs problem in Europe" (PDF). Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Archived from the original (PDF) on 2009-11-16. Retrieved 2009-11-05.
"Reports: Miami 'zombie' attacker may have been using 'bath salts'". CNN. May 29, 2012. Archived from the original on March 25, 2021. Retrieved May 29, 2012.

webmd.com

"K2 Trend Not Slowing Down". WebMD. Retrieved 2018-05-12.

worldcat.org

Turnock, Luke; Gibbs, Nick (2023-06-01). "Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK". Performance Enhancement & Health. 11 (2): 100251. doi:10.1016/j.peh.2023.100251. ISSN 2211-2669.

zenodo.org

Reepmeyer JC, Woodruff JT, d'Avignon DA (2007). "Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement". J Pharm Biomed Anal. 43 (5): 1615–21. doi:10.1016/j.jpba.2006.11.037. PMID 17207601.